Tocilizumab (Acterma) is an immunosuppressive drug (IL-6 inhibitor) mainly used in the treatment of rheumatoid arthritis and is currently being tested in COVID-19 patients.
Tags: ACE, ACE2, ALBUMIN, ANGIOTENSIN II, APOE, BLOOD VESSEL DISEASE, COVID-19, FIBRINOGEN, HEMOGLOBIN, ICAM1, IL1B, IL6, LACTATE DEHYDROGENASE, NFKB1, RAS, SARS-COV-2, THROMBIN, TNF, VEGFA